Harbin Medisan Pharmaceutical Co.,Ltd.’s Net Profit Dropped 96.5% in First Three Quarters of 2022

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net profit of 18.6 million yuan in the first three quarters of 2022, down 96.5% year-on-year.

Meanwhile, the company posted 761.9 million yuan in revenue, up 7.7% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 37.3%.